Search
for
Sort by
Research 631–660 of 688
- [Commentary] The Polyfollicular Anovulatory Androgenic Syndrome: A New Label for an Old Syndrome
- Approach to Investigation of Hyperandrogenism in a Postmenopausal Woman
- The influence of ESR1 polymorphisms on selected hormonal, metabolic and mineral balance markers in women with hyperandrogenism
- Association of Acne Tarda with Endocrinological Disorders
- Polycystic ovary syndrome: Diagnosis and management
- Ameliorative Impact of High Inositol Diet on the Insulin Resistance and Metabolite Hormones among Women with Polycystic Ovary Syndrome
- Recent Approaches in the Treatment of Polycystic Ovary Syndrome: An Update
- Rare and Underappreciated Causes of Polycystic Ovarian Syndrome
- Clinical Observation of Polycystic Ovary Syndrome Treatment with Resveratrol
- A Rare Case of Adolescent Girl with Beard-PCOS with a Difference: “HAIR-AN Syndrome”
- Left ventricular myocardial mass index and its correlates as an early marker of cardiovascular risk among nonobese normotensive Indian women with polycystic ovary syndrome: lessons from a cross-sectional study
- Prevalence of Cutaneous Disorders in Patients with Polycystic Ovary Syndrome
- CUTANEOUS MANIFESTATIONS OF POLYCYSTIC OVARIAN DISEASE
- Dunnigan-Type Familial Partial Lipodystrophy: Understanding and Treating the Syndrome
- Update on Polycystic Ovary Syndrome
- Genetic screening of non-classic CAH females with hyperandrogenemia identifies a novel CYP11B1 gene mutation
- Polycystic ovary syndrome [PCOS]: Comprehensive management in primary care
- Polycystic ovary syndrome: etiology, pathogenesis and diagnosis
- 2014 Female Athlete Triad Coalition Consensus Statement on Treatment and Return to Play of the Female Athlete Triad: 1st International Conference held in San Francisco, California, May 2012 and 2nd International Conference held in Indianapolis, Indiana, May 2013
- Role of insulin, insulin‐like growth factor‐1, hyperglycaemic food and milk consumption in the pathogenesis of acne vulgaris
- Metformin treatment of polycystic ovary syndrome improves health-related quality-of-life, emotional distress and sexuality
- Mediators of Inflammation in Polycystic Ovary Syndrome in Relation to Adiposity
- Congenital Adrenal Hyperplasia
- Hirsutism, Normal Androgens and Diagnosis of PCOS
- Metformin therapy for the reproductive and metabolic consequences of polycystic ovary syndrome
- The evaluation of endothelial function with flow-mediated dilatation and carotid intima media thickness in young nonobese polycystic ovary syndrom patients; existence of insulin resistance alone may not represent an adequate condition for deterioration of endothelial function
- Prevalence and accurate diagnosis of polycystic ovary syndrome in adolescents across world regions: a systematic review and meta-analysis
- When should an insulin sensitizing agent be used in the treatment of polycystic ovary syndrome?
- Adverse event reporting of four anti-Calcitonin gene-related peptide monoclonal antibodies for migraine prevention: a real-world study based on the FDA adverse event reporting system
- Manifestation of Hyperandrogenism in the Continuous Light Exposure-Induced PCOS Rat Model